This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Changchun Huapu Biotechnology Co. Ltd.. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Innovations of Musheng Bao in Biotechnology
Introduction
Musheng Bao is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the development of adjuvants for vaccines. His work focuses on enhancing the immune response to various vaccines, which is crucial for public health.
Latest Patents
Musheng Bao holds a patent for "CpG single strand deoxynucleotides for use as adjuvant." This invention provides an adjuvant that includes at least one single strand deoxynucleotide containing a CpG dinucleotide. The single strand deoxynucleotide comprises one or more CpG dinucleotides. When used in combination with rabies vaccine, HBV vaccine, or other vaccines, this adjuvant can significantly improve the immune effect of the vaccine.
Career Highlights
Musheng Bao is associated with Changchun Huapu Biotechnology Co. Ltd., where he applies his expertise in biotechnology to develop innovative solutions. His work has been instrumental in advancing vaccine technology and improving health outcomes.
Collaborations
Some of his notable coworkers include Liying Wang and Yongli Yu, who collaborate with him on various projects within the biotechnology sector.
Conclusion
Musheng Bao's contributions to vaccine adjuvants represent a significant advancement in biotechnology. His innovative work continues to impact the field positively, enhancing vaccine efficacy and public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile